1. Home
  2. GD vs MRNA Comparison

GD vs MRNA Comparison

Compare GD & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo General Dynamics Corporation

GD

General Dynamics Corporation

SELL

Current Price

$358.42

Market Cap

89.6B

Sector

Industrials

ML Signal

SELL

Logo Moderna Inc.

MRNA

Moderna Inc.

SELL

Current Price

$215.86

Market Cap

91.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GD
MRNA
Founded
2019
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.6B
91.2B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
GD
MRNA
Price
$358.42
$215.86
Analyst Decision
Buy
Hold
Analyst Count
24
23
Target Price
★ $419.29
$158.47
AVG Volume (30 Days)
1.2M
★ 12.9M
Earning Date
10-30-2026
11-06-2026
Dividend Yield
★ 1.75%
N/A
EPS Growth
13.35
★ 21.77
EPS
★ 15.45
N/A
Revenue
★ $52,550,000,000.00
$19,263,000,000.00
Revenue This Year
$8.21
$24.04
Revenue Next Year
$5.25
$10.79
P/E Ratio
$23.48
★ N/A
Revenue Growth
★ 10.13
4.29
52 Week Low
$306.77
$22.28
52 Week High
$400.00
$280.80

Technical Indicators

Market Signals
Indicator
GD
MRNA
Relative Strength Index (RSI) 51.92 47.11
Support Level $337.39 $181.02
Resistance Level $360.12 $254.48
Average True Range (ATR) 9.08 17.19
MACD -0.46 -3.89
Stochastic Oscillator 27.42 16.00

Price Performance

Historical Comparison
GD
MRNA

About GD General Dynamics Corporation

General Dynamics is a defense contractor and business jet manufacturer. The firm's segments are aerospace, marine, combat systems, and technologies. General Dynamics' aerospace segment manufactures Gulfstream business jets and operates a global aircraft servicing operation. Combat systems produces land-based combat vehicles such as the M1 Abrams tank and Stryker armored personnel carrier, as well as munitions. The marine segment builds and services nuclear submarines, destroyers, and support ships. The technologies segment contains two main units: an IT business that primarily serves the government market and a mission systems business focusing on electronics that provide command, control, computing, intelligence, surveillance, and reconnaissance capabilities to the military.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: